Partner news
News
Partner news
Study Results of Novocure's NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
Read full storyPartner news
Mitralign Raises $35 Million Series D Financing
Read full storyPartner news
Novocure Announces Launch of Recurrent Glioblastoma Product Website
Read full storyPartner news
Celladon Corporation Completes Second Close of Recent Venture Financing
Read full storyPartner news